Allergan 2Q Revenues: $4.1 billion (+3%) 2Q Earnings: $2.0 billion (+5%) FY Revenues: $7.8 billion (+3%) FY Earnings: $3.7 billion (+7%) Comments: U.S. Specialized Therapeutics revenues grew 7% in the quarter to $1.8 billion, driven primarily by growth in Medical Aesthetics, including BOTOX Cosmetic, ALLODERM and the addition of CoolSculpting, as well as growth in BOTOX Therapeutic. In Neurosciences & Urology, BOTOX Therapeutic revenues were $404.7 million, up 17%. In Eye Care RESTASIS ...